JDD Buzz Series | Sunscreen Practices & Preferences in Skin of Color Patients
Sunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen.
I interviewed author Jared Jagdeo, MD, MS, associate professor of dermatology and director …
Sunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen.
I interviewed author Jared Jagdeo, MD, MS, associate professor of dermatology and director … Continue reading "JDD Buzz Series | Sunscreen Practices & Preferences in Skin of Color Patients"
Alopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment options exist; however, there is minimal evidence in the pediatric population. Currently, there are no curative treatments for AA. The literature suggests that Janus kinase (JAK) inhibitors may be an effective t … 
In this June edition of the Journal of Drugs in Dermatology (JDD), we're excited to showcase a selection of groundbreaking research and expert insights that delve into the latest advancements and treatments in dermatology. From innovative acne scar therapies to in-depth analyses of topical acne treatments, this month's featured articles provide a comprehensive overview of current dermatological … 
Mohs Micrographic Surgery effectively removes skin cancer while preserving healthy tissue. But what happens when the procedure that’s supposed to help maintain aesthetics leads to long-lasting and highly distressing cosmetic outcomes?
That’s the focus of an observational study published in the May issue of the Journal of Drugs in Dermatology. Researchers looked at the factors that contribut … 
Tranexamic acid is one of the latest therapies for treating melasma, and one that’s most commonly prescribed for women. An editorial published in the April issue of the Journal of Drugs in Dermatology encourages dermatology clinicians to also consider the effect melasma has on men and to utilize tranexamic acid as a treatment option.
I interviewed the authors, dermatologist and Mohs surgeon A …